Private company
GV 2017, L.P.
American company, incorporated in Delaware. Summary from the record
Last updated Oct 21, 2026.
Overview
- HeadquartersDE1
Corporate structure
GV 2017, L.P. sits at the top of its group. 5 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
- GV 2017, L.P. DE
- Benson Hill, Inc. Stake · St. Louis, Missouri
- GitLab Stake · San Francisco, California
- TScan Therapeutics, Inc. Stake · Waltham, Massachusetts
- Verve Therapeutics, Inc. Stake · Boston, Massachusetts
Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (4 companies). Each entity in the chart links to its source.
Stakes it holds
GV 2017, L.P. has told the SEC it owns more than 5% of 4 companies, latest first (Schedules 13D and 13G).
- Verve Therapeutics, Inc.SCHEDULE 13G/A Feb 14, 2022 to Jul 28, 20252
- GitLabSCHEDULE 13G/A Feb 14, 2022 to Feb 13, 20253
- Benson Hill, Inc.SC 13G/A Feb 14, 2022 to Nov 8, 20244
- TScan Therapeutics, Inc.SC 13G/A Feb 14, 2022 to Feb 9, 20245
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARGV 2017, L.P. filings on SEC EDGAR
- 2
- 3
- 4
- 5